MedPath

To compare the combined efficacy of internal administration of Jeevantyadi ghrita and Mahatriphaladya ghrita tarpana with Mahatriphaladya Ghrita Tarpana alone in Simple myopia

Phase 2
Conditions
Health Condition 1: H521- Myopia
Registration Number
CTRI/2022/02/040241
Lead Sponsor
Athira K Prasad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients attending the OPD of our research institute in age group between 15 to 30 years having simple myopia will be randomly selected.

2. Patients having a vision of 6/9 or less ie.,6/12, 6/18, 6/24,6/36,6/60

3. Patients having refractive error -0.5D to -3.00D

Exclusion Criteria

1. Patients having any known systemic disorders will be excluded from the study

2. Patients having any other known ocular pathology eg. Cataract, corneal opacity, H/o iridocyclitis, retinal pathologies.

3. Patients suffering from eye disorders of systemic origin

4. Patients below the age of 15 years and above 30 years are excluded

5. Non Co - operative patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the combined effect of Jeevantyadi ghritapana and Mahatriphaladya Ghrita tarpana in Timira with respect to simple myopiaTimepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
To assess the efficacy of shamana snehapana in simple myopia <br/ ><br>To assess the local effect of Tarpana in management of Timira with special reference to Simple MyopiaTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath